Furthermore, breast cancer exhibited high SP100 expression with favorable outcomes, mediated by ETS1 repression and IFN-α modulation, highlighting a tumor-suppressive role for SP100 distinct from other cancers [11, 36]. This evidence concerns the gene ETS1 and neoplasm.